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Abstract
Background: Spermatogonial stem cell (SSC) transplantation (SSCT) has become important for conservation of
endangered species, transgenesis and for rejuvenating testes which have lost germ cells (Gc) due to gonadotoxic
chemotherapy or radiotherapy during the prepubertal phase of life. Creating a germ cell-depleted animal model for
transplantation of normal or gene-transfected SSC is a prerequisite for such experimental studies. Traditionally used
intraperitoneal injections of busulfan to achieve this are associated with painful hematopoietic toxicity and affects
the wellbeing of the animals. Use of testicular busulfan has been reported recently to avoid this but with a very low
success rate of SSCT. Therefore, it is necessary to establish a more efficient method to achieve higher SSCT without
any suffering or mortality of the animals.
Methods: A solution of busulfan, ranging from 25 μg/20 μl to 100 μg/20 μl in 50 % DMSO was used for this study.
Each testis received two diagonally opposite injections of 10 μl each. Only DMSO was used as control. Germ cell
depletion was checked every 15 days. GFP-expressing SSC from transgenic donor mice C57BL/6-Tg (UBC-GFP)
30Scha/J were transplanted into busulfan-treated testis. Two months after SSCT, mice were analyzed for presence of
colonies of donor-derived SSC and their ability to generate offspring.
Results: A dose of 75 μg of busulfan resulted in reduction of testis size and depletion of the majority of Gc of testis
in all mice within 15 days post injection without causing mortality or a cytotoxic effect in other organs. Two
months after SSCT, colonies of donor-derived Gc-expressing GFP were observed in recipient testes. When
cohabitated with females, donor-derived offspring were obtained. By our method, 71 % of transplanted males sired
transgenic progeny as opposed to 5.5 % by previously described procedures. About 56 % of progeny born were
transgenic by our method as opposed to 1.2 % by the previously reported methods.
Conclusions: We have established an efficient method of generating a germ cell-depleted animal model by using
a lower dose of busulfan, injected through two diagonally opposite sites in the testis, which allows efficient
colonization of transplanted SSC resulting in a remarkably higher proportion of donor-derived offspring generation.
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Background
Fertility of males in mammalian species depends upon
the production of sperm through the process of sperm-
atogenesis. Spermatogonial stem cells (SSC) are the male
germline stem cells which stand to be the foundation of
spermatogenesis. SSC are present on the basal mem-
brane of the seminiferous tubules in the testis and sur-
rounded by Sertoli cells, which function as an important
component of the SSC niche [1]. SSC differentiate and
divide to form the mature spermatozoa. In 1994, Brinster
and Zimmerman first demonstrated the possibilities of
isolation and transplantation of SSC into an evacuated
testis followed by successful spermatogenesis from the
transplanted SSC [2]. Since then, this approach has been
explored to address various issues like transgenesis [3, 4],
infertility [5], conservation of endangered species [6], and
for understanding the biology of male germinal stem cells
and its niche [3], etc. Fertility preservation is an important
issue in the management of the quality of life of prepuber-
tal boys undergoing gonadotoxic cancer therapy because
sperm cryopreservation is not possible for them due to
sexual immaturity at that phase of development [7]. Pres-
ently, the only theoretical option for preservation of fertil-
ity in these boys is the preservation of the SSC for
intratesticular stem cell transplantation [8, 9]. The major
requirement for successful germ cell transplantation
(GCT) is the preparation of germ cell-depleted recipients
(GCD) in which endogenous Gc are destroyed, creating
space for the transplantation of exogenous SSC [10, 11].
Various approaches like irradiation [12], heat shock treat-
ment [13], and chemical treatment have been adopted to
generate evacuated testis to prepare recipients for GCT.
The sole chemical treatment most commonly used for the
preparation of recipients is through intraperitoneal (i.p.)
injection of busulfan [14] due to its easy handling and
availability [14]. Busulfan (1,4-butanediol dimethane sul-
fonate), a DNA alkylating agent is often used to kill en-
dogenous Gc, creating an empty space in the basal and
adluminal compartment of seminiferous tubules prior to
SSC transplantation [14]. It mediates cytotoxic effects
through the formation of DNA-DNA cross-links, DNA-
protein cross-links and single-strand breaks. Busulfan ex-
erts its toxic effects on cells that are at the G0/G1 phase
of the cell cycle [15, 16]. Intraperitoneal administration of
busulfan preferentially kills proliferating cells including
spermatogonial stem cells, leading to male infertility [17].
But there are several drawbacks of this existing technique
of creating GCD by i.p. injection of busulfan. It takes
almost 6 weeks for successful depletion of Gc. Busulfan
doses, less than 40 mg/kg given to adult mice did not re-
sult in prolonged depletion of endogenous spermatogen-
esis in most tubules [14]; higher doses often caused severe
hematopoietic suppression requiring bone marrow trans-
plantation and resulted in death [18]. Therefore it was
hypothesized that after i.p. injection, busulfan may be
absorbed and transferred to other organs via blood circu-
lation and exert a nonspecific cytotoxic effect on the body
by destroying other cellular niches of the body resulting in
bone marrow depression and anemia.
To overcome these drawbacks, an alternative method
of testicular busulfan injection was explored in sheep
[19] where busulfan was directly injected in the scrotal
region, but transplantation experiments were not carried
out in this species. Recently, the testicular route was ex-
plored in rodents [20, 21], but is much less efficient.
Only 4 out of 335 pups originated from donor SSC
which were transplanted exogenously in mouse testes
treated directly with 120–180 μg of busulfan [21]. Only
1 out of 18 recipient mice transplanted with SSC sired 4
transgenic pups, displaying a success rate of 5.5 % [21].
Therefore, the aim of the present study was to explore a
method to achieve more Gc depletion and a relatively
higher success rate of Gc transplantation to increase effi-
ciency of direct testicular busulfan treatment. The suc-
cess rate of GCT is directly correlated to the efficiency
of generating donor Gc-derived offspring.
Here, we have established a method of testicular bu-
sulfan injection which requires lower dose of busulfan to
prepare recipients for GCT while achieving the objective
of maximum Gc depletion without any cytotoxic effect
in other organs. The success rate by our method is 56 %
which is about severalfold more as compared to 1.2 %
shown earlier [21]. This method is fast, efficient and eth-
ically superior as it will utilize fewer animals to generate
more information.
Methods
Animals
Six-week-old F1Bl6SJL (F1 hybrid of Bl6 and SJL) and
FVB mice were used for busulfan treatment and as re-
cipients for SSC transplantation. Six-week-old GFP-
expressing transgenic C57BL/6-Tg (UBC-GFP)30Scha/J
male mice were used as donors of testicular Gc. All mice
were bred and maintained at the Small Animal Facility
of the National Institute of Immunology. All mice were
kept at 24 ± 2 °C under a 14 hours light and 10 hours
dark cycle and used as per the National Guidelines pro-
vided by the Committee for the Purpose of Control and
Supervision of the Experiments on Animals (CPCSEA).
Protocols for the experiments were approved by the
Institutional Animal Ethics Committee.
Busulfan treatment (BST)
Busulfan (Sigma-Aldrich, St Louis, MO, USA) was dis-
solved in dimethyl sulfoxide (DMSO, Sigma-Aldrich),
and then an equal volume of sterile water was added to
obtain an aqueous solution of busulfan. This was main-
tained at 42 °C until injection, with frequent vortexing,
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to prevent the busulfan from crystallizing. Six-week-old
recipient male mice (body weight approximately 30 g)
were randomly distributed into various testicular busulfan
treatment groups (T-BST).The mice were injected with
various doses of busulfan, i.e., 25 μg (T-BST-25) or 50 μg
(T-BST-50) or 75 μg (T-BST-75) or 100 μg (T-BST-100)
delivered in a total volume of 20 μl through two different
injection sites (approximately 10 μl per injection) in each
testis. The negative control group received testicular injec-
tion of 50 % DMSO in 20 μl distilled water (T-DMSO).
The intraperitoneal busulfan treatment group (IP-BST) re-
ceived injections of 40 mg/kg busulfan [2, 22, 23]. Mice
were anesthetized by intraperitoneal injection (200 μl) of
ketamine hydrochloride (45 mg/kg) and xylazine hydro-
chloride (8 mg/kg) before busulfan or DMSO treatment.
For testicular injections of busulfan, hair was removed
from the lower abdominal and scrotal area of the mice.
The area was then wiped with betadine (povidone iodine)
followed by 70 % ethanol. The testes were gently squeezed
from the abdominal cavity into the scrotum. Busulfan so-
lution containing 0.04 % Trypan blue, which was used to
monitor the accuracy of the injection, was injected slowly
into the testis using the 10-μl Hamilton syringe (701 N;
Hamilton Bonaduz AG, Switzerland). The injection was
given at two different and diagonally opposite sites of the
testes (10 μl at each site, 20 μl/testis) covering the whole
testes (Additional file 1: Figure S1a and b). After injection,
the site was again wiped with betadine solution and mice
were kept under lamps until consciousness was regained.
Mortality rate, body weight and testicular weight post
BST
After busulfan treatment, the mice were euthanized by
cervical dislocation at 15, 30, 60 and 90 days respectively
and the body weight of mice from each group was re-
corded. Testicular size and testicular weight of the mice
was measured at day 15 post BST. Mortality rate was
observed in busulfan-treated mice.
Histological analysis
Testes and liver tissue of the BST and control mice were
dissected, washed briefly in PBS and fixed in 4 % para-
formaldehyde for 18–20 hours. After complete dehydra-
tion in a graded series of ethanol and permeabilization
in xylene, the tissues were embedded in paraffin, sec-
tioned at 5 μm using Reicher Jung, 2040; Microtome
(Leica Biosystems, Nussloch Germany).Tissue histology
was performed as described by us previously [24].
Testicular tissue sections were stained with hematoxylin
and eosin for histological examination for evaluating the
status of spermatogenesis and were observed under
bright field illumination with Nikon Eclipse TE2000-S
inverted microscope (Nikon Corporation, Tokyo, Japan)
attached to a DS-5 M camera assisted by Digital Sight
DS-L1 software for capturing the images.
Routine blood analysis
After 15 days of T-BST-75 injection, peripheral blood
from experimental and wild-type control mice (Wt-Ctrl)
were collected by retro-orbital bleeding in tubes with
EDTA according to Hoff ’s method [25]. White blood
cells (WBC), red blood cells (RBC), platelets (PLT) and
hemoglobin (Hb) along with other hematological param-
eters were analyzed using an automated analyzer (MS
Pharmaceuticals, Amman, Jordan).
Sperm count and fertility assessment post BST
After 15 days of T-BST-75 injection, the number of epi-
didymal spermatozoa were analyzed by counting total
numbers of sperm present in each cauda epididymis
after releasing the sperm in 1 ml of 1X PBS by punctur-
ing the epididymis at several sites. The total sperm count
was determined using a hemocytometer under a light
microscope. For analysis of litter size, after 15 days of
busulfan injections three T-BST-75-treated males were
cohabitated with age-matched female mice and number
of offspring produced was recorded.
Preparation of donor testicular germ cells
Testicular Gc from the 6-week-old transgenic C57BL/6-
Tg(UBC-GFP) 30Scha/J transgenic donor mice were iso-
lated using the procedure adapted from Bellve et al.,
1977 and Guan et al., 2006 [26, 27] with little modifica-
tions. Briefly, testes obtained post castration of male
mice were decapsulated and washed in HBSS before
mincing. Minced testicular tissue was washed in HBSS,
to eliminate blood cells and non-adherent interstitial
cells as supernatant. The sedimented seminiferous tu-
bules were suspended in 25 ml of prewarmed collage-
nase solution (1200 U collagenase/25 ml HBSS)
containing 100 Kunitz units (KU) of deoxyribonuclease
(DNase) and the digestion was carried out at 34 °C for
10 minutes in a shaking water bath at 120 oscillations/
minute. Ten milliliters of supernatant was carefully
aspirated at this point, and kept on ice. Collagenase di-
gestion was resumed for the remaining 15 ml of semin-
iferous tubules for 15 to 20 minutes, until most of the
seminiferous tubules got finely digested. The cell-rich
suspension was carefully aspirated and the tissue debris
and detritus were discarded. The tissue suspension
(approximately 24 ml) was distributed into four 15 ml
polypropylene conical tubes, which were centrifuged for
5 minutes at 600 rpm (127 g) at 4 °C. The supernatant
was aspirated and centrifuged at 2500 rpm for 5 minutes
at 4 °C. The pellet was resuspended in 15 ml HBSS
and the cells were dispersed by pipetting. The cell
suspension was allowed to stand at 4 °C for 5 minutes,
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to allow the sedimentation of heavier somatic cells,
tissue aggregates, etc. The upper cell suspension was
aspirated and the sediment was discarded. Cell suspen-
sion was centrifuged at 2500 rpm to obtain a dense cell
pellet.
Antibody staining and FACS-mediated sorting of
testicular cells
The dense cell pellet containing crude preparation of Gc
was incubated with mouse CD 90.2 antibody (Ab) dir-
ectly conjugated to PE (phycoerythrin) at 1:100 dilution
with sterile 1XPBS for 45 minutes. CD90.2 is a marker
for SSC of the testis. A small fraction of cells previously
separated were used as a control during sorting. Un-
bound antibody was removed by washing with cold
HBSS and cells were subsequently suspended in filtered
DMEM with 1 % serum and filtered through 70-μm fil-
ter (BD Biosciences, San Jose, CA, USA). Unstained frac-
tion of cells were likewise washed and filtered. Such
stained and unstained cell suspensions were filtered
using a 100-μm filter to obtain clump-free cells and fur-
ther used for FACS-mediated SSC isolation using BD
FACS Aria III cell sorter (BD Biosciences, USA). The
CD90.2/PE-positive cells were sorted with an 85-μm
nozzle at 45 psi sheath pressure and at a flow rate of
3000 events per second in the “4-way purity” mode. The
sorted cells were collected in DMEM supplemented with
2 % FCS. Laser 561 was used for excitation of the PE
signals.
Culture, expansion and transplantation of spermatogonial
stem cells
SSC selected by FACS using CD90.2 antibody were cul-
tured in vitro [27]on Matrigel-coated plates in a defined
growth factor medium. Culture media consisted of
Stem-Pro34 SFM medium, 1X Stem-Pro34 supplement,
1X N2 supplement, 1X MEM vitamin, 1X nonessential
amino acids, 30 ng/ml β-estradiol, 60 ng/ml progesterone,
1000 U/ml leukemia inhibitory factor (LIF), 10 ng/ml
basic fibroblast growth factor (bFGF), 10 ng/ml glial
fibriliary-derived nerve growth factor (GDNF), 10 μg/ml
insulin, 5 μg/ml transferrin, 5 μg/ml sodium selenite,
2 mM L-glutamine, 6 mg/ml D-(+) glucose, 30 μg/ml
pyruvic acid, D-L lactic acid, 5 mg/ml bovine albumin,
50 μM beta mercaptoethanol, 2.5 ng/ml epidermal growth
factor (EGF) and 1 % FCS. Cells were maintained at 34 °C
and 5 % CO2 environment. The cells were maintained in
culture for several days to increase their numbers. Fifteen
days after testicular busulfan injection, these cells were
transplanted into testis of T-BST-75. Briefly, 0.5–1.0 × 105
of cells were suspended in 10 μl PBS along with 0.4 % Try-
pan blue tracking dye and transplanted into the seminifer-
ous tubules of the testes of recipient mice through the
efferent duct injection using a 50-μm glass micropipette
controlled by a FemtoJet microinjector. The success of the
injection was monitored by observing the distribution of
the Trypan blue dye in the convoluted seminiferous tu-
bules. The mice were sacrificed 2 months later, and the
testes were examined under a fluorescence stereo zoom
microscope to detect GFP expression.
Analysis of recipient testes after SSC transplantation
Sixty days post transplantation, the testes of the trans-
planted and non-transplanted T-BST-75 recipients were
dissected and observed for GFP expression under SMZ-
1500 stereo-zoom microscope (Nikon Corporation,
Tokyo, Japan) fitted with an epi-fluorescence attach-
ment. Images were captured using a DS-5 M camera
with Digital sight DS-LI software. Epididymal sperm
count was done as described before. The testes were
fixed in 4 % paraformaldehyde for 18–20 hours at 4 °C
and processed as mentioned previously. Testicular tissue
sections were stained with hematoxylin and eosin and
were observed under light microscope for evaluating the
status of spermatogenesis.
Immunohistochemistry on testicular sections of trans-
planted recipients were performed according to the
method described by us previously [28] using mouse
anti-GFP antibody (Clontech, Mountain View, CA,
USA) diluted at 1∶250 and incubated overnight at 4 °C.
The slides were then exposed to an Alexa Fluor-488-
conjugated goat anti-mouse immunoglobulin G (IgG)
(Molecular Probes, Eugene, OR, USA) antibody (1∶250
dilution) for 4 hours at room temperature. Sections were
analyzed under bright field and ultraviolet illumination
(a FITC filter) using a Nikon Eclipse TE2000-S inverted
microscope (Nikon Corporation, Tokyo, Japan) attached
to a DS-5 M camera assisted by Digital Sight DS-L1
software for capturing the images.
For western blot analysis, total protein was isolated
from testes and liver tissues using RIPA (radio-immuno-
precipitation assay) lysis buffer [24, 29].Protein concentra-
tion was determined using the Bradford assay (Bio-Rad
Laboratories, Hemel Hempstead, UK). The samples were
boiled in the SDS sample buffer for 5 minutes and were
subjected to SDS-PAGE, followed by western blot analysis
using primary mouse monoclonal anti-GFP (Santa Cruz
Biotechnology, Dallas, TX, USA) antibody at a dilution of
1:2500 and incubated for overnight at 4 °C while the
secondary HRP-conjugated anti-mouse IgG antibody
(Thermo Fisher Scientific, Waltham, MA, USA; number
31430) at a dilution of 1:5000 for 1 hour at room
temperature. β-actin was used as an internal control. For
β-actin detection, blot was incubated overnight at 4 °C
with rabbit antiserum against β-actin (1:3000) and second-
ary goat anti-rabbit IgG-HRP antibody (Thermo Fisher
Scientific; number 353-1) at a dilution of 1:5000 for 1 hour
at room temperature.
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Fertility assessment of GCT mice and analysis of
transgenic offspring
Germ cell-transplanted (T-BST-75-GCT) mice were
cohabitated with age-matched wild-type females (ratio
1:1) for 10 days after 2 months of busulfan injection to
obtain F1 progeny. Since the transplanted SSC were iso-
lated from transgenic mice expressing GFP, pups gener-
ated (F1 generation) were analyzed for the presence of
GFP by PCR using genomic DNA (gDNA) obtained
from their tail tips.
The transgene integration of a few PCR-positive mice
were further confirmed by slot blot analysis [30]. A
transgene-specific probe was prepared by amplifying a
fragment that contained GFP gene (630 bp) using the
P1: GACGTAAACGGCCACAAGTT, P2: GGCGGTCA
CGAACTCCAG primers by PCR. Probes for slot blot
analysis were radioactively labeled using αP32dCTP by
random priming using a High Prime kit from Roche, fol-
lowing the manufacturer’s instructions (Roche Diagnostic
GmbH, Mannheim, Germany). About 1 μg of gDNA was
blotted on membrane and hybridized with a transgene-
specific probe for detection of transgene in the progeny.
Total protein was isolated from the liver of a few slot
blot-positive animals and western blot analysis was per-
formed using the procedure described above.
Unilateral testicular busulfan treatment
Busulfan was also injected at two sites in a single testis
of mice to determine its efficacy in Gc depletion.
Validation of T-BST-75 in other strains of mice
After standardizing the T-BST-75 dose of busulfan in
the 1B6SJL hybrid strain of mice, the same dose was val-
idated in the FVB/J strain of mice also.
Results
Effect of BST on body weight
There was no significant difference in the body weight
of all the tested groups 15 and 30 days post BST. How-
ever, after 60 and 90 days of BST, the body weights were
significantly (p < 0.0001) reduced in IP-BST group mice
in comparison to T-BST and control group mice where
the body weight increased with increase in age after bu-
sulfan injection (Fig. 1a).
Effect of BST on testicular parameters
Macroscopic observation of testis at day15 post injection
revealed a remarkable reduction in testes size of T-BST-
75 and T-BST-100 injected animals as compared to that
of control animals (Fig. 1b; Additional file 1: Figure S2).
Testicular weight of T-BST-75 and T-BST-100was sig-
nificantly (p < 0.0001) reduced in comparison to T-BST-
25, T-BST-50, IP-BST and control group mice after
15 days of busulfan injection (Fig. 1c).Testicular size and
weights proportionally decreased with increase in dose
of busulfan injection. Lowest testicular weight was ob-
served in T-BST-75 (26.23 mg) and T-BST-100 (23.33 mg)
at day 15 post BST (Fig. 1c).
Histological morphology of BST mice
Histological evaluation of testicular sections of T-BST-
25 and control mice did not show any effect as semin-
iferous tubules of such testes remained undisturbed
showing all the stages of spermatogenesis in the semin-
iferous tubules of these mice (Fig. 1d i and v). Testicular
sections of T-BST-50 mice revealed partial evacuation,
as spermatogenesis was observed in many tubules with
presence of many Gc in the innermost and middle layers
of the seminiferous tubules (Fig. 1d ii). Seminiferous tu-
bules of T-BST-75 and T-BST-100 mice showed multiple
vacuoles, thin-walled seminiferous epithelium and
complete absence of sperm (Fig. 1d iii and iv). T-BST-75
had maximum depletion of Gc leaving behind only Ser-
toli cells in the evacuated tubules (Fig. 2a). T-BST-100
also produced the similar effect as T-BST-75 but T-
BST-100 mice showed severe tubular disorganization
(Additional file 1: Figure S3). The tubular diameter and
circumference was significantly (p < 0.05) reduced in
T-BST-75 mice (Fig. 2b, c) as the atrophy was very
prominent in this group of mice (Additional file 1: Figure
S4).The effect of depletion of Gc was observed across the
whole testis (Additional file 1: Figure S5).
Survival rate of testicular busulfan-treated mice
None of the BST mice which were given testicular injec-
tions of busulfan (T-BST) died during the entire course
of study (100 % survival) in comparison to the IP-BST
mice where the mortality rate was 20 % after 90 days
(80 % survival) of IP-BST and 60 % after 150 days (40 %
survival) of IP-BST respectively. No mortality was ob-
served in DMSO-treated control mice (Fig. 2d).
Since, the mortality rate was high in the IP-BST group
and no decrease in testicular weight of the IP-BST group
mice was observed at day 15 post BST, they were not an-
alyzed for further studies. Since complete depletion of
Gc was not observed during testicular and histological
examination of T-BST-25 and T-BST-50 mice, these
doses were not used for further studies. T-BST-100 also
produced a similar effect as T-BST-75 but T-BST-100
mice showed severe tubular disorganization in compari-
son to T-BST-75, which never showed any unusual tis-
sue organization, so of the two doses; higher dose,
i.e.100 μg, was not used for further analysis. Therefore,
the 75 μg dose (T-BST-75) was selected as the most ap-
propriate dose for testicular busulfan injection for max-
imal depletion of Gc from the testis in 15 days and was
used for further studies.
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Effect of BST on peripheral blood cell counts
No suppression in peripheral blood counts was observed
in T-BST-75 mice in comparison to wild-type control
mice (Wt-ctrl). The white blood cell (WBC) counts did
not show any significant (p > 0.05) difference in both the
groups (Fig. 3a). Red blood cell (RBC) counts and
hemoglobin were also similar and did not show any signifi-
cant (p > 0.05) difference in both the groups (Fig. 3a, b).
Mean corpuscular hemoglobin and hematocrit levels
were also significantly similar (p > 0.05) in both groups
(Fig. 3c, d). There was no significant (p > 0.05) differ-
ence in the levels of platelets too (Fig. 3e). None of the
T-BST-75 mice required bone marrow transplantation
as hematopoietic suppression was not observed in any
of the mice.
Effect of BST on sperm count and litter size
Fifteen days post busulfan injection, no sperm was de-
tected in T-BST-75 mice in comparison to T-DMSO
mice where the sperm count was 3.5 million/ml
(Fig. 3f ). T-BST-75 mice were found to be infertile
as they failed to produce any offspring when they
were cohabitated with age-matched females, 15 days
post BST.
Fig. 1 Effect of various doses of testicular busulfan treatment. a Changes in body weight of mice injected with various doses of busulfan after 15,
30, 60, and 90 days post BST. Significant (p < 0.0001) reduction in the body weight was observed in IP-BST mice (n = 3). b Macroscopic observation of
testis injected with various doses of busulfan at day 15 post BST. Decrease in testis size with increase in dose of busulfan was observed. Remarkable
reduction was found in testis size of T-BST-75 and T-BST-100 mice. c Mean testis weight of mice injected with various doses of busulfan. Significant
(p < 0.0001) reduction was observed in testis weight of T-BST-75 and T-BST-100 mice (n = 3). d Hematoxylin and eosin-stained sections of testes,
injected with different doses of busulfan at the day 15 post BST. (i) No effect was observed in T-BST-25 mice. (ii) Partial evacuation of seminiferous
tubule was observed in T-BST-50 mice. (iii) Maximum depletion of germ cells with intact testicular architecture was observed in T-BST-75 mice. (iv)
Maximum depletion of germ cells with disturbed testicular architecture was observed in T-BST-100 mice. Scale bar: 100 μm. T-BST-25, T-BST-50, T-BST-75,
T-BST-100 denotes mice injected with 25 μg, 50 μg, 75 μg, and 100 μg of busulfan in each testes respectively. T-DMSO denotes control mice injected
with DMSO. IP-BST denotes mice injected intraperitoneally with busulfan
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Restoration of endogenous spermatogenesis after BST
Restoration of endogenous spermatogenesis without
SSCT was initiated in few tubules 2 months after busul-
fan injection (Fig. 3g).
Restoration of fertility in T-BST-75 infertile recipient mice
by germ cell transplantation of in vitro expanded
transgenic SSC
Donor SSC from C57BL/6-Tg(UBC-GFP)30Scha/J mice
carrying GFP transgene, sorted through FACS (Additional
file 1: Figure S6) and expanded in stem cell-specific media
(Additional file 1: Figure S7 and S8) were transplanted in
the evacuated T-BST-75 testis of F1BL6SJL recipient mice
(Additional file 1: Figure S9). The GCT mice were housed
for 2 months for colonization of transplanted SSC (Fig. 4a,
b). Two months post transplantation, the testicular weight
of GCT mice had increased significantly (p < 0.0001,
37 mg) as compared to non-transplanted T-BST-75 con-
trol mice (28 mg) (Fig. 4c). Epididymal sperm count from
GCT mice was also found to be significantly (p < 0.0001)
higher (0.61 million/ml) than that of non-transplanted T-
BST-75 mice (0.007 million/ml) at 2 months post GCT
(Fig. 4d). Transplanted testes also showed in vivo GFP ex-
pression under stereo-zoom microscope with a FITC filter
upon excitation with UV, which was absent in non-
transplanted testes (Fig. 4e). Western blot analysis of total
protein from GCT testes showed the presence of 28 KDa
protein corresponding to GFP, which reconfirmed
colonization of GFP-expressing donor SSC (Fig. 4f ).
Immunostaining of GCT testes showed GFP expression
confirming colonization of transplanted donor SSC
(Fig. 4g). GFP expression was observed in the trans-
planted testes only, but not in the non-transplanted
T-BST-75 mice testes.
Fertility assessment of GCT mice at 2.5 months post BST
Germ cell transplanted (T-BST-75-GCT) mice were
cohabitated with age-matched wild-type females for
10 days after 2 months of busulfan injection to obtain
F1 progeny pups. There was no delay in pregnancy of fe-
male mice which were mated with T-BST-75-GCT mice
and pups were obtained between 19–21 days of gestation
period with average litter size of three pups per mouse
(Fig. 5a). Out of 34 GCT males set for mating (1:1
Fig. 2 Effect of T-BST-75 on the testicular morphology of mice. a A magnified image of hematoxylin and eosin-stained testicular sections of
T-BST-75 mice. Maximum depletion of Gc leaving behind only Sertoli cells in the evacuated tubules was observed. Black arrowhead marks the
nucleus of Sertoli cells, red arrowhead marks the cytoplasm of Sertoli cells which was intact in T-BST-75 mice, green arrowhead marks the peritubular
cells. i, ii and iii are testicular sections from three different mice. Scale bar: 20 μm. b Mean tubular diameter (under same magnification) of T-BST-75
mice as compared to T-DMSO control mice. A significant (p < 0.05) decrease in tubular diameter was observed in T-BST-75 mice. c Mean tubular
circumference of T-BST-75 mice as compared to T-DMSO control mice. A significant (p < 0.05) decrease in tubular circumference was observed
in T-BST-75 mice. d Survival rate of mice injected with various doses of busulfan and those treated with vehicle. Survival rate was found to be
significantly (p < 0.05) reduced in IP-BST mice (n = 5). T-BST-25, T-BST-50, T-BST-75, and T-BST-100 denotes mice injected with 25 μg, 50 μg,
75 μg, and 100 μg of busulfan in each testes respectively. T-DMSO denotes mice injected with DMSO in testes. IP-BST denotes mice injected
with busulfan, intraperitoneally
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scheme, total 34 females) at 2.5 months post BST, 24
males sired 69 pups. The average litter size of T-BST-75-
GCT mice, which was three initially at 2.5 months post
BST, gradually increased to seven after 4 months of BST
(Fig. 5a). No pups were obtained in non-transplanted T-
BST-75 control (T-BST-75-NT) mice, when set for mat-
ing after 2.5 months of BST but pups were obtained
after 4 months of BST treatment (data not shown). The
average litter size of T-BST-75-NT mice was less (two
pups) in comparison to T-BST-75-GCT mice, which
showed an average litter size of seven after 4 months of
busulfan injection.
Generation and analysis of transgenic offspring
Sixty-nine pups born from T-BST-75-GCT mice were
analyzed for the presence of transgene by PCR and slot
blot analysis. The presence of 633 bp band in PCR ana-
lysis showed the amplification of GFP transgene (Fig. 5b).
Fig. 3 Effect of T-BST-75 on peripheral blood counts and studies of restoration of endogenous spermatogenesis after BST. a–e Graphs showing
changes in levels of white blood cells (WBC), red blood cells (RBC), hemoglobin, platelets, and hematocrit of T-BST-75 mice as compared to
wild-type control (Wt-Ctrl) mice. No suppression in peripheral blood counts was observed in T-BST-75 mice. f Graph showing caudal epididymal
sperm count in T-BST-75 mice 15 days post BST as compared to T-DMSO control mice. No sperm was detected in T-BST-75 mice. (n = 3, p < 0.005).
g Hematoxylin and eosin-stained testicular sections of T-BST-75 mice dissected 2 months after BST. Only a few of the non-spermatogenic tubules
showed recovery of spermatogenesis at 2 months after BST. Black arrowhead marks the sperm, red arrowhead marks the tubules, in which
spermatogenesis has not yet initiated, green arrowhead marks the proliferating Gc. All data were recorded 15 days post BST unless mentioned
otherwise. T-BST-75 denotes mice injected with 75 μg of busulfan in each testes, T-DMSO denotes mice injected with DMSO in testes
Ganguli et al. Stem Cell Research & Therapy  (2016) 7:142 Page 8 of 13
Slot blot analysis of PCR-positive pups confirmed the
presence of transgene (Fig. 5c). Western blot analysis
of the protein isolated from the liver of slot blot-
positive pups showed the presence of 28 KDa protein
corresponding to GFP, which reconfirmed that the off-
spring of GCT mice had originated from transgenic
donor SSC (Fig. 5d). Immunostaining of liver sections
of slot blot-positive pups showed GFP expression con-
firming the presence of transgene (Fig. 5e). Out of 69
pups analyzed, 39 pups were found to express GFP
(56 % transgenic efficiency). All 24 females which were
impregnated by T-BST-75-GCT male mice sired
donor-derived transgenic pups with average transgenic
efficiency of 56 %.
Fig. 4 Restoration of fertility in T-BST-75 mice after GCT. a Hematoxylin and eosin-stained testicular sections of T-BST-75-GCT mice. Complete
stages of spermatogenesis were observed in many tubules. Several tubules only showed initial stages of spermatogenesis. Few tubules were also
seen in which spermatogenesis was not started. Black arrowhead marks the sperm, green arrowhead marks the proliferating Gc. Scale bar: 100 μm.
b A magnified image of hematoxylin and eosin-stained testicular sections of T-BST-75-GCT mice. Black arrowhead shows two Gc which were
harbored in a single evacuated space, yellow arrowhead marks the basement membrane. Scale bar: 100 μm. c Mean testis weight of T-BST-75-GCT
mice as compared to non-transplanted control mice. A significant (p < 0.0001) increase in testes weight was observed in the transplanted testes
(n = 10). d Mean sperm count of T-BST-75-GCT mice as compared to non-transplanted control mice. A significant (p < 0.0001) increase in sperm
count was observed in the transplanted testes (n = 10). e In vivo GFP expression in T-BST-75-GCT testes as compared to non-transplanted control
testes 2 months after GCT. GFP expression was observed in transplanted testes. i Image under bright field stereo-zoom microscope. ii Image
under UV with FITC filter. Yellow dotted line marks the transplanted testis. White dotted line marks the non-transplanted testis. f Western blot of total
protein isolated from T-BST-75-GCT testes as compared to wild-type testis. Transplanted testis showed presence of 28 KDa protein corresponding to
GFP. β-actin was used as internal control. g Immunostaining showing GFP expression in the Gc of seminiferous tubules of T-BST-75-GCT testis. GFP
expression was observed specifically in Gc of the testis. i and ii shows testicular sections of GCT testis. iii and iv shows testicular sections of
non-transplanted testes. Yellow arrowhead shows GFP expression in the Gc. Scale bar: 100 μm. All data were recorded 2 months after GCT
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Unilateral testicular treatment for depleting germ cells in
single testis
We also experimented to evacuate single testis of mice
through direct testicular injection of busulfan. Seventy-
five micrograms of busulfan dose was administered in
single testis of a mouse keeping the contralateral testis
as control. Macroscopic observation after 15 days of
BST revealed that the T-BST-75 testes were smaller in
size as compared to that of non-injected contralateral
control testes (Additional file 1: Figure S10). Histological
observation of T-BST-75 testes showed almost complete
depletion of Gc leaving behind only Sertoli cells in the
evacuated tubules. The effect of busulfan was confined
to a single testis only. This effect was similar to the ef-
fect observed by giving busulfan injection in both testes.
The contralateral control testes showed no cytotoxic
effect of busulfan as the testis was intact and organized,
showing all stages of Gc.
Validation of T-BST-75 in other strains of mice
After standardizing the T-BST-75 dose of busulfan in
F1B6SJL hybrid strain of mice, we validated the same
dose in FVB/J strain of mice. A 75 μg dose was found to
be equally effective in the FVB strain of mice and was
successful in depleting the Gc and evacuating the seminifer-
ous tubules in 15 days after busulfan injection (Additional
file 1: Figure S11).
Discussion
We have established an efficient method of testicular bu-
sulfan injection that required lower dose of busulfan to
prepare recipients for GCT while achieving the objective
Fig. 5 Generation and analysis of transgenic offspring. a Litter size and number of transgenic positive pups in F1 generation of each litter sired
by T-BST-75-GCT mice. A significant (p < 0.0001) increase in litter size of subsequent F1 generations was observed with same T-BST-75-GCT males
(n = 10). b PCR screening for transgene positive pups in a litter sired by T-BST-75-GCT mice. Lanes 1, 3, and 5 shows the presence of transgene in
gDNA of pups. M denotes NEB 1 kb DNA ladder; NT denotes no template control, +Ve denotes plasmid positive, 1–5 denotes lanes with gDNA
of pups; Wt denotes gDNA of wild-type mice. c Slot blot for confirmation of transgene in PCR positive pups. Six out of eight (slot 1–8) showed
strong positive hybridization for transgene. Wt denotes gDNA of wild-type mice, +Ve denotes plasmid positive. d Western blot of total protein
isolated from liver of transgene positive pups. All the transgenic pups showed GFP expression in the liver samples as compared to wild-type.
β-actin was used as internal control. e Immunostaining showing GFP expression in the liver sections of transgenic pups. i and ii show liver sections of
transgenic pups. iii and iv show liver sections of wild-type mice. Scale bar: 100 μm
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of maximum Gc depletion without any cytotoxic effect
in other organs. Our method is very efficient in terms of
offspring generated (56 %) from SSC-transplanted males;
rapid in terms of time required to evacuate testis using
lowest effective dose of busulfan (75 μg) without any
systemic ill effect. The success rate of our method for
obtaining donor-derived offspring is very high (71 %) as
compared to such methods reported recently by other
group (5.5 %) as only 1 out of 18 Gc-transplanted mice
could generate offspring from transplanted SSC in their
study [21].
For this study, we have used F1B6SJL strain of mice
for initial standardization of busulfan dosage for direct
administration into the testes to prepare recipient mice
prior to SSCT. We tested several doses of testicular bu-
sulfan (25 μg, 50 μg, 75 μg, and 100 μg) and found that
the 75 μg dose provided desirable results as compared to
a recently reported method [21] where 6 mg/kg-1dose
(approximately 180 μg busulfan per testis) was selected
as an appropriate dose for recipient preparation. This is
2.4 times more than ours (75 μg/testis).
There have been several reports which showed that i.p.
injections of busulfan can cause systemic toxicity includ-
ing severe bone marrow depression and/or death of ani-
mals [4, 12, 31]. In our study, no mortality was observed
in testicular BST mice while i.p. injection of busulfan
caused 60 % mortality. This confirmed that direct ad-
ministration of busulfan in testis at a lower dose did not
induce any cytotoxic effect on the hematopoietic system.
The body weight of T-BST and control group mice in-
creased with age unlike the IP-BST group where the
body weight remained low as compared to age-matched
untreated animals.
Testicular size and weight proportionally decreased
with increase in dose of busulfan injection. Lowest tes-
ticular weight was found in T-BST-75 and T-BST-100 at
day 15 post BST. This was followed by a significant de-
crease in the tubular diameter. The prominent decrease
in the diameter of the seminiferous tubule might have
occurred due to depletion of the luminal contents. This
was supported by histological observations like depletion
of Gc, presence of multiple vacuoles, absence of sperm
and presence of hollow cavities in the seminiferous tu-
bules of T-BST. Maximum depletion of Gc was observed
in T-BST-75 and T-BST-100 group mice 15 days post
BST but T-BST-100 mice showed severe tubular
disorganization which was not discernible in T-BST-75
mice. The depletion of Gc with our method was 7 days
earlier than the one reported recently using 6 mg/ kg-1
testicular busulfan where maximum depletion was no-
ticed at day 21 after BST [20, 21]. The major difference
between our procedures is the use of two diagonally op-
posite sites for testicular injection of busulfan by us and
from a single site through the tail end of testis by them
[20, 21]. We injected busulfan from two sites (10 μl at
each site) through both ends (the upper as well as lower
end of the testis) covering the whole testicular area,
thereby the effect of busulfan was more pronounced. In a
previously reported study, injection was given from the
testicular tail side along the long axis of the testis. In the
process of travelling from one end to another, busulfan
may get diluted by testicular lymph nodes thereby requir-
ing higher doses and duration for the desirable effect.
None of the T-BST-75 mice required bone marrow
transplantations as hematopoietic suppression was not
observed in any of the mice, as opposed to conventional
way of busulfan administration (i.p.) where whole body
gets exposed to this cytotoxic drug causing depletion of
various stem cell populations in other body organs too.
Restoration of endogenous spermatogenesis without
SSCT was observed in few seminiferous tubules at
2 months after busulfan injection and gradually increased
with time showing maximum restoration by 4 months.
Since non-spermatogenic state of the BST-T-75 mice was
attained at 15 days post BST, transplantation experiments
may be performed 25 days earlier in contrast to the con-
ventional method (i.p.). In the conventional method, Gc
depletion and removal of sloughed off Gc occur by 6 weeks
after busulfan injection, after which the transplantation
experiments are performed [32]. However, by our method,
GCT can be performed 25 days earlier. Also with our
method, the depleted state of the testis is sustained for a
longer period (>1 month) thereby increasing the window
for undertaking transplantation studies.
Donor-derived germ cell colonies in testes of T-BST-
75 recipients showing GFP expression were observed
within 2 months post transplantation, indicating suc-
cessful GCT. In all, 24 out of 34 such males could suc-
cessfully impregnate females within 10 days of
cohabitation. However, males treated with busulfan but
not transplanted with SSC (n = 3) could impregnate fe-
males only at 4.5 months after BST. Based on this, it
may be assumed that out of 34 T-BST-75 mice,
attempted for GCT, 24 were transplanted successfully
and efficiently because of which they (71 % success rate)
sired pups at about 2.5–3 months after BST. Out of 69
offspring analyzed, 39 were found to be transgene posi-
tive (56 % transgenic efficiency). This transgenic effi-
ciency rate with our method of BST is very high in
comparison to 1.2 % shown previously as only 4 out of
335 pups were found to be transgene positive originated
from donor SSC which were transplanted exogenously
[21] and all these offspring were born from only 1 of the
18 recipient mice, with success rate of 5.5 % only [21].
The reason for their low efficiency might reside in re-
markably reduced cytoplasm of Sertoli cells observed in
the cross section of testes due to busulfan treatment, at
doses higher than ours (120–180 μg as compared to
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75 μg used by us). They also have transplanted SSC at a
time when the testis was not sufficiently depleted of Gc,
reducing their efficiency. Our method is hence, superior
to the previously suggested method.
Unilateral testicular busulfan treatment for depleting
Gc in single testis was quite effective by our method
without any nonspecific cytotoxic effect of busulfan on
any other organ including contralateral testis. While in
the conventional i.p. route of busulfan administration,
whole body get exposed to this cytotoxic drug, which
causes the depletion of other stem cell population in the
body, this unilateral testicular treatment may be advan-
tageous for many studies where one testis can be used
for experimental purpose and contralateral testis may be
used as an internal control.
Our method of recipient preparation using the F1B6SJL
strain of mice, when checked in other strains of mice was
found to be equally effective and successful in evacuating
the seminiferous tubules in 15 days after busulfan injec-
tion. We also suggest that species-wise doses of busulfan
could be selected for better effect at the lowest dose, caus-
ing damage to SSC but sparing other cell types of the tes-
tes like Sertoli cells or Leydig cells, which help restoration
of spermatogenesis. It has also been reported in the past
that higher doses of busulfan also affect the Sertoli cells
and Leydig cells [33].
Here, we have established an efficient method of Gc
depletion by testicular busulfan injection using a lower
dose of busulfan to prepare GCD recipients while
achieving the objective of maximum Gc depletion with-
out any cytotoxic effect to other organs. The success rate
by our method is 56 % which is severalfold more as
compared to 1.2 % shown earlier [21]. Our method is
fast, efficient, and ethically superior as it will utilize less
animals to generate more information.
Conclusions
We have established an efficient method of generating a
germ cell-depleted animal model by using a lower dose of
busulfan, injected through two different and diagonally op-
posite sites in the testis, which allows efficient colonization
of transplanted SSC and leads to a remarkably higher pro-
portion of donor-derived offspring generation.
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